PEAK6 Investments L.P. boosted its stake in LivaNova PLC (NASDAQ:LIVN) by 349.5% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 30,414 shares of the company’s stock after buying an additional 23,648 shares during the quarter. PEAK6 Investments L.P. owned approximately 0.06% of LivaNova worth $2,131,000 at the end of the most recent quarter.
Other hedge funds also recently added to or reduced their stakes in the company. Airain ltd purchased a new stake in LivaNova in the 2nd quarter worth approximately $1,449,000. Virginia Retirement Systems ET AL purchased a new stake in LivaNova in the 2nd quarter worth approximately $2,277,000. Redmile Group LLC purchased a new stake in LivaNova in the 2nd quarter worth approximately $12,978,000. Hosking Partners LLP lifted its position in LivaNova by 1.6% in the 2nd quarter. Hosking Partners LLP now owns 188,518 shares of the company’s stock worth $11,539,000 after buying an additional 3,048 shares in the last quarter. Finally, Russell Investments Group Ltd. purchased a new stake in LivaNova in the 2nd quarter worth approximately $957,000. Institutional investors own 86.07% of the company’s stock.
In other news, Director Alfred J. Novak sold 2,000 shares of the stock in a transaction on Wednesday, November 22nd. The shares were sold at an average price of $85.77, for a total transaction of $171,540.00. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Daniel Jeffrey Moore sold 1,000 shares of the stock in a transaction on Friday, September 15th. The stock was sold at an average price of $68.55, for a total transaction of $68,550.00. Following the transaction, the director now owns 57,296 shares in the company, valued at approximately $3,927,640.80. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 6,830 shares of company stock worth $557,100. 0.28% of the stock is currently owned by company insiders.
LivaNova PLC (LIVN) opened at $83.73 on Thursday. LivaNova PLC has a 12 month low of $44.58 and a 12 month high of $88.56. The company has a market cap of $3,989.02, a price-to-earnings ratio of 23.84, a PEG ratio of 2.48 and a beta of 0.61. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.42 and a current ratio of 2.03.
LivaNova (NASDAQ:LIVN) last announced its quarterly earnings results on Thursday, November 2nd. The company reported $0.93 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.76 by $0.17. LivaNova had a net margin of 4.63% and a return on equity of 9.33%. The company had revenue of $309.70 million for the quarter, compared to analyst estimates of $301.22 million. During the same quarter in the prior year, the business posted $0.78 EPS. LivaNova’s quarterly revenue was up 4.9% on a year-over-year basis. research analysts forecast that LivaNova PLC will post 3.33 earnings per share for the current year.
COPYRIGHT VIOLATION WARNING: “LivaNova PLC (LIVN) Shares Bought by PEAK6 Investments L.P.” was originally reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this story on another domain, it was illegally stolen and reposted in violation of United States and international trademark and copyright legislation. The original version of this story can be accessed at https://www.tickerreport.com/banking-finance/3078977/livanova-plc-livn-shares-bought-by-peak6-investments-l-p.html.
LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.
Want to see what other hedge funds are holding LIVN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for LivaNova PLC (NASDAQ:LIVN).
Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with MarketBeat.com's FREE daily email newsletter.